- Open Access
Gene dysregulation by histone variant H2A.Z in bladder cancer
© Kim et al.; licensee BioMed Central Ltd. 2013
- Received: 6 June 2013
- Accepted: 27 September 2013
- Published: 16 October 2013
The incorporation of histone variants into nucleosomes is one of the main strategies that the cell uses to regulate the structure and function of chromatin. Histone H2A.Z is an evolutionarily conserved histone H2A variant that is preferentially localized within nucleosomes at the transcriptional start site (TSS). H2A.Z reorganizes the local chromatin structure and recruits the transcriptional machinery for gene activation. High expression of H2A.Z has been reported in several types of cancers and is causally linked to genomic instability and tumorigenesis. However, it is not entirely clear how H2A.Z overexpression in cancer cells establishes aberrant chromatin states and promotes gene expression.
Through integration of genome-wide H2A.Z ChIP-seq data with microarray data, we demonstrate that H2A.Z is enriched around the TSS of cell cycle regulatory genes in bladder cancer cells, and this enrichment is correlated with the elevated expression of cancer-promoting genes. RNAi-mediated knockdown of H2A.Z in the cancer cells causes transcriptional suppression of multiple cell cycle regulatory genes with a distinct decrease in cell proliferation. H2A.Z nucleosomes around the TSS have higher levels of H3K4me2/me3, which coincides with the recruitment of two chromatin factors, WDR5 and BPTF. The observed recruitment is functional, as the active states of H2A.Z target genes are largely erased by suppressing the expression of WDR5 or BPTF, effects resembling H2A.Z knockdown.
We conclude that H2A.Z is overexpressed in bladder cancer cells and contributes to cancer-related transcription pathways. We also provide evidence in support of the engagement of H3K4me2/me3 and WDR5/BPTF in H2A.Z-induced cancer pathogenesis. Further studies are warranted to understand how H2A.Z overexpression contributes to the recruitment of the full repertoire of transcription machinery to target genes in bladder cancer cells.
- Bladder cancer
- Gene expression
Gene expression in eukaryotes takes place in the context of chromatin, which essentially acts as a physical barrier to the binding of transcription factors to certain genomic regions. The basic unit of chromatin is the nucleosome, which consists of approximately 147 bp of DNA wrapped around an octamer of four core histones (H2A, H2B, H3, and H4) . Despite its high degree of compaction, chromatin structure is dynamically modulated to allow access of genomic DNA during vital cellular processes. Several remodeling processes that alter chromatin structure have been identified and categorized based on their modes of action. The three most prominent processes are histone modification, histone variant exchange and adenosine triphosphate (ATP)-dependent chromatin remodeling [2–5]. Histone variants are nonallelic isoforms of canonical core histones that have been identified primarily from the H2A and H3 families in numerous organisms. Although expressed in smaller amounts than canonical histones, histone variants are involved in a variety of cellular activities with specific genomic localization patterns.
H2A.Z is an essential variant of the histone H2A and has distinct functions in regulating chromatin dynamics. At the amino acid sequence level, H2A.Z shares about 60% identity with canonical H2A in mammalian cells . As for other histone variants, the replacement of histone H2A with H2A.Z is replication-independent and is catalyzed by ATP-dependent exchange factors. H2A.Z preferentially localizes at the transcription start site (TSS) where it frequently flanks nucleosome-deficient regions [7–11]. The presence of H2A.Z at the −1 and +1 nucleosomes adjacent to the TSS has been linked to dynamic changes in gene expression [12–15], but the underlying mechanism is not fully understood. Since H2A.Z-containing nucleosomes wrap DNA more weakly than canonical H2A nucleosomes, they are more susceptible to nuclease digestion and salt-induced destabilization [16, 17]. This structural instability is most likely driven by amino acid substitutions at the interface between H2A.Z and H3/H4 . Consistent with its effects on gene transcription, the presence of H2A.Z correlates with active histone modifications and RNA Pol II occupancy at gene promoters, which in turn influence transcriptional output [7, 13, 19]. These observations are in agreement with the concept that H2A.Z creates an active transcription environment by altering DNA accessibility in chromatin and facilitating the recruitment of transcription regulators. Of special relevance to the present study, overexpression and redistribution of H2A.Z have been noted as epigenetic processes to stimulate the development and progression of certain types of cancer [20–23]. The oncogenic function of H2A.Z is mediated through increased cell proliferation caused by cell cycle deregulation. Therefore, the important questions to address are how H2A.Z maintains chromatin in a certain state, and whether H2A.Z overexpression observed in cancer cells drives the inappropriate activation of cancer-related genes.
In this work, we exploited microarray and chromatin immunoprecipitation sequencing (ChIP-seq) to examine the impact of H2A.Z overexpression on transcriptional states of bladder cancer cells, and identified groups of genes, the dysregulation of which is linked to H2A.Z enrichment around the TSS. We also found that H2A.Z nucleosomes are enriched for the active histone modification H3K4me2/me3 that is likely responsible for recruiting WDR5 and BPTF to H2A.Z target genes.
H2A.Z is overexpressed in bladder cancer cells and stimulates cell proliferation
We next checked whether the high-level expression of H2A.Z in cancer cells contributes to cell growth over a period of four days. The 3–4, 5-(dimethyl-thyazol-2-yl)-2, 5-diphenyltetrazolium (MTT) assays reproducibly showed that LD611 cancer cells expressing high levels of H2A.Z grow much faster compared to normal UROtsa cells (Figure 1D). These findings were further corroborated by the results showing that the ectopic expression of H2A.Z led to a significant increase in the growth of UROtsa cells (Figure 1E and Additional file 1: Figure S1). To evaluate the effects of H2A.Z overexpression more directly, endogenous H2A.Z was depleted in LD611 cells by using a lentiviral shRNA infection system, and changes in cell growth were analyzed. Western blotting confirmed that the stable transfection of H2A.Z shRNA efficiently silenced H2A.Z expression in the cell (Additional file 1: Figure S2). The MTT assays clearly showed that suppressing H2A.Z expression decreased the growth of LD611 cells (Figure 1F). These observations are consistent with the hypothesis that H2A.Z is one of the key players governing proliferation of bladder cancer cells.
H2A.Z shows a unique localization pattern in bladder cancer cells
H2A.Z redistribution correlates with increased expression of proliferation-related genes
When we analyzed a group of the positively regulated proto-oncogenes (BIRC3, CCND, DDX43, FADD, MEN1, NT5E, POLDIP2, PPFIA1, STK3, and YAP1), we detected a robust signal for H2A.Z around the TSS (Figure 3C, LD611). In the normal bladder cells, these genes displayed much lower levels of H2A.Z (UROtsa). To further validate the ChIP-seq and gene expression data, we selected the 10 active genes from the H2A.Z regulon and performed conventional ChIP assays. Expectedly, H2A.Z enrichment was evident in these genes in the bladder cancer cells, but similar assays in the normal cells showed minimal accumulation of H2A.Z (Figure 3D). Moreover, there was a significant correlation between H2A.Z enrichment and gene activation, as evidenced by qRT-PCR analysis (Figure 3E). To the best of our knowledge, this is the first report linking H2A.Z enrichment to active transcription states in bladder cancer cells.
WDR5 and BPTF preferentially interact with H2A.Z nucleosomes
A noteworthy observation emerged from our purification was substantial interactions of H2A.Z nucleosomes with WDR5 and BPTF, which are known to interact with H3K4me tails and play important roles in regulating chromatin function [26–28]. The observed interactions are specific, as H2A nucleosomes failed to interact with these two factors (Figure 4E). Further analyses revealed that the overall levels of neither H3K9me3 nor H3K27me3 were altered in H2A.Z nucleosomes (Figure 4F, α-H3K9me3 and α-H3K27me3). However, in the same nucleosome samples, H2A.Z nucleosomes showed much higher levels of H3K4me2/me3 as compared to H2A nucleosomes (α-H3K4me2 and α-H3K4me3). These results underscore the notion that the observed binding of WDR5 and BPTF depends on their ability to recognize H2A.Z-facilitated H3K4me2/me3 in the nucleosome.
H2A.Z-mediated gene activation requires WDR5 and BPTF
Because WDR5 and BPTF are necessary for H2A.Z to upregulate gene transcription in the bladder cancer cells, we also check whether they are functionally linked to H2A.Z-induced cell growth. As summarized in Figure 5B, when H2A.Z was depleted in the LD611 cancer cells, the growth of the cancer cells was significantly inhibited over a four-day period. More importantly, knockdown of WDR5 or BPTF had the same inhibitory effect as knockdown of H2A.Z. In accordance with these results, individual knockdown of H2A.Z, WDR5 and BPTF also reduced cell migration severely, displaying about 70% lower migration than control cells (Figure 5C). Considered together, these findings demonstrate that H2A.Z functions cooperatively with WDR5 and BPTF to stimulate the expression of tumorigenic genes.
H2A.Z is essential for H3K4me and WDR5/BPTF recruitment
These data raised the question of whether colocalization of WDR5 and BPTF at the target genes is dependent on H2A.Z-promoted H3K4me2/me3. In fact, the predicted effects of H2A.Z were confirmed by the observation that the levels of H3K4me2/me3, WDR5 and BPTF at the target loci were reduced in response to H2A.Z knockdown. On the contrary, knockdown of WDR5 or BPTF did not have substantial effects on H2A.Z occupancy around the TSS, placing WDR5 and BPTF in later steps of chromatin remodeling. Moreover, H3K4me3 and BPTF localization at the target genes decreased sharply upon WDR5 knockdown, suggesting that BPTF is recruited to the target genes via its physical recognition of WDR5-facilitated H3K4me3. Because the conversion of H3K4me2 to H3K4me3 is attenuated in WDR5-depleted cells, we detected a sharp increase in H3K4me2 over the TSS and CR of the target genes. As expected from the qRT-PCR results (Figure 5A), ChIP analysis showed no enrichments of H2A.Z, WDR5 and BPTF at the CASP8 gene, which did not alter after individual depletion of H2A.Z, WDR5, and BPTF (Additional file 1: Figure S6). In view of the importance of H3K4me2/me3 for WDR5/BPTF recruitment, we also suspected that H2A.Z target genes may be selectively enriched for H3K4me2/me3, WDR5 and BPTF after ectopic H2A.Z expression in the normal cells. Indeed, when stably expressed in the UROtsa cells, ectopic H2A.Z produced a distinct increase in the levels of H3K4me2/me3 at the target genes and thereby facilitated the recruitments of WDR5 and BPTF (Additional file 1: Figures S7A and S7B). Consistent with these data, ectopic expression of H2A.Z in the normal cells increased target gene expression and cell migration (Additional file 1: Figures S7C and S7D). These results strongly argue that H2A.Z, WDR5 and BPTF function coordinately in regulating growth-controlling genes and their concerted actions are linked to H3K4me2/me3.
Despite significant efforts to understand altered expression and functional deregulation of H2A.Z in human cancer, we are still in the early stages of mechanistic studies for its contribution toward cancer development. Given the close correlation between H2A.Z exchange and gene activation in the context of chromatin, H2A.Z has been implicated in upregulating the network of genes during carcinogenesis. To gain deeper understanding of oncogenic effects of H2A.Z, we analyzed H2A.Z localization and function in bladder cancer cells by ChIP-seq and gene expression array. Our analysis of H2A.Z-enriched genes in bladder cancer cells revealed a significant overrepresentation for tumorigenic genes in general. By comparing transcriptional profiles, we found that approximately 28% of the H2A.Z-enriched genes are activated, whereas only approximately 5% of the genes are repressed, in the cancer cells. This is significant because H2A.Z is known to regulate transcription positively or negatively. However, the changes in the expression and localization of H2A.Z in bladder cancer cells mainly correlate with gene activation, with the most activated genes tending to be related to cell growth regulation. Thus, our data favor the mechanism in which the elevated expression and redistribution of H2A.Z contribute to selective, rather than general, disruption of transcription integrity in bladder carcinoma cells. The fact that H2A.Z knockdown affects the same sets of genes in cancer cells further confirms that H2A.Z is a critical driving force for the tumorigenic transcriptional output. This study represents the first genome-wide analysis of H2A.Z in bladder cancer cells, and establishes H2A.Z as a key component whose enrichment near the TSS drives expression of major cell cycle regulatory genes capable of facilitating cell growth and proliferation. Recent studies in human osteosarcoma (U2OS) cell line showed that H2A.Z is incorporated into the p21 promoter region in p53-dependent manner, and establishes a repressive barrier to p53-mediated p21 induction . However, we did not observe any significant change in p21 transcription after H2A.Z knockdown in LD611 cells (data not shown). Furthermore, our ChIP-seq data indicate that H2A.Z is incorporated into p21 promoter nucleosomes at low levels in both LD611 and UROtsa cells. These results imply that H2A.Z-catalyzed oncogenic pathway in bladder cancer cells is minimally dependent on a negative behavior of H2A.Z toward p21 gene.
Although the mechanism by which H2A.Z promotes chromatin transcription remains unclear, our interaction data demonstrated that the presence of H2A.Z in the nucleosome increases the levels of H3K4me2 and H3K4me3, marks that are associated with gene activation. These results are in good agreement with those of recent studies showing that H2A.Z colocalizes with active histone modifications in transcription regulatory regions [7, 10, 30–32]. It is also conceivable that H2A.Z-induced H3K4me2/me3 at the TSS coincides with the recruitment of WDR5 and BPTF, which are essential components of the MLL H3K4-methyltransferase complex and the NURD ATP-dependent remodeling complex, respectively [33–35]. This suggests that H2A.Z is an integral part of histone modification-mediated factor recruitment processes and has a direct role in resetting transcription competency of growth-regulatory genes in bladder cancer. A recent study reported copurification of WDR5 with H2A.Z nucleosomes, but BPTF was absent in the purified H2A.Z nucleosomes . Clearly, these differences could be due to different purification approaches (for example, single-step purification using the Flag-tag moiety in the previous study versus two-step purification using Flag and HA tags in the current study) and different wash conditions (150 mM NaCl versus 300 mM NaCl). We speculate that the weak binding of BPTF to H2A nucleosomes is not preserved under our stringent purification conditions. It is also noteworthy that H2A.Z nucleosomes isolated from bladder cancer cells display the levels of the two repressive histone marks, H3K9me3 and H3K27me3, similar to those of H2A nucleosomes. Thus, although further work will be required to gain a complete understanding of how H2A.Z functionally interacts with various histone modifications, these findings nevertheless illustrate that H2A.Z overexpression in bladder cancer cells is likely to act in concert with active histone modifications which establish constitutive expression of the target genes.
We show that H2A.Z is overexpressed in bladder cancer cells and establishes the active states of oncogenic transcription. H2A.Z enrichments at target genes increase the levels of H3K4me2 and H3K4me3, which in turn facilitate the recruitments of WDR5 and BPTF. These results unveil a specific contribution of H2A.Z to chromatin remodeling in bladder cancer cells and emphasize the importance of accurate levels of H2A.Z expression to prevent the onset of tumorigenesis.
Cell culture, constructs and antibodies
LD611 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS). UROtsa cells were cultured in DMEM containing 2 mg/ml glucose and 5% FBS. For mammalian expression of H2A and H2A.Z, their cDNAs were amplified by PCR and ligated into the NheI and BamHI sites of pIRES expression vector containing 5′ Flag and HA coding sequences. Antibodies used in this study are as follows: H2A, H2A.Z, H3K4me1 and WDR5 antibodies from Abcam (Cambridge, UK), Actin, HA and Flag antibodies from Sigma-Aldrich (St Louis, MO, USA), BPTF antibody from Bethyl Laboratories (Montgomery, TX, USA), H3K4me3 and H3K9me3 antibodies from Active Motif (Carlsbad, CA, USA), and H3K27me2 and H3K27me3 antibodies from Merck Millipore (Darmstadt, Germany).
Tissue microarrays and immunohistochemistry
The expression patterns of H2A.Z were determined in human bladder tissue microarrays, which include 16 cases of bladder malignant tissues and eight cases of normal bladder tissues (US Biomax, Rockville, MA, USA). The tissues were deparaffinized, treated with 3% hydrogen peroxide to block endogenous peroxide, and subjected to antigen retrieval with citrate buffer (10 mM, pH 6.0). The tissue sections were blocked in 5% normal goat serum in Tris-buffered saline-Triton X-100 (TBST, 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 0.3% Triton X-100) for 30 min at room temperature and incubated with H2A.Z antibody at 4°C overnight. Immunodetection was performed using Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA) according to manufacturer’s recommendations. DAB (Vector Laboratories) and hematoxylin (Sigma-Aldrich) were used for color development and counterstaining. The staining intensity was evaluated by semiquantitative immunohistochemical assessment, and divided into four categories: negative staining (less than 20% of cells), weak staining (21 to 50% of cells), moderate staining (51 to 80% of cells) and strong staining (more than 80% of cells).
H2A.Z ChIP for UROtsa normal and LD611 bladder cancer cell lines (1 × 108 cells) was carried out following a standard protocol as described previously . Briefly, cells were fixed for 10 min in 1% formaldehyde, and chromatin was sheared with a bioruptor (Diagenode, Denville, NJ, USA) to an average size of 200 to 500 bp. Lysates were clarified by centrifugation at 20,000 × g for 15 min at 4°C, and incubated with anti-H2A.Z antibody overnight. Protein A/G agarose beads were added to protein complexes for 60 min at 4°C. Immunoprecipitates were washed three times in wash buffer (20 mM Tris–HCl, pH 8.0, 300 mM NaCl, 2 mM EDTA, 0.1% SDS, and 1% Triton X-100), once in LiCl buffer (10 mM Tris–HCl, pH 8.0, 1% deoxycholate, 1 mM EDTA, 0.25 M LiCl, and 1% NP-40), twice in TE buffer (10 mM Tris–HCl, pH 8.0 and 1 mM EDTA) and then eluted in elution buffer (1% SDS and 0.1 M NaHCO3). Crosslinking was reversed by overnight incubation at 65°C. After RNase A (200 μg/ml) and proteinase K (200 μg/ml) digestions, ChIP DNA was purified by phenol-chloroform extraction and ethanol precipitation. The high-throughput DNA sequencing was performed using Illumina HiSeq 2000 (Illumina, San Diego, CA, USA) at the University of Southern California (USC) Genomic Core.
ChIP-seq data analysis
Approximately 17 and 13 million sequences were generated for the normal and cancer cells, respectively. MAQ was used to generate 14 and 11 million aligned reads to hg18 reference genome (mapping quality score ≥20) . One of the duplicated sequences was kept to minimize the artifacts of PCR amplification. Since we used single-end sequencing, each read was extended in the sequencing orientation to a total of 250 bases to infer the coverage at each genomic position. The genome was divided into non-overlapping windows, and aligned read was considered to be within a window of the midpoint of its estimated fragment. Mid-points in each window were counted, and empirical distributions of windows counts were created. The Java-based EpiChIP software was used to identify optimal sequence window with respect to gene coordinates for analysis of H2A.Z enrichment at all Reference Sequence (RefSeq) genes. In this analysis, normalized ChIP-seq signal for each gene (area below the peak and within window) was quantified to yield NLCS (normalized locus-specific chromatin state) value by using expectation and maximization algorithm and a curve fitting model of Baysen information criteria as previously described [24, 38]. The mapping output files were also converted to browser-extensible data (BED) files. For visualization, wiggle tracks were generated by computing mean read density over 25 bp bins of human genome with aligned and filtered reads from UROtsa and LD611 ChIP-seq data. Wiggle tracks were visualized in the IGV (Integrated Genomic Viewer) . K-means clustering was performed on ChIP-seq tag density around 3 kb regions across the TSS in R statistical software (http://www.r-project.org).
Gene expression microarray
Total RNA was isolated from LD611 and UROtsa cells using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Gene expression microarray experiments were conducted using a whole-genome expression array (Human HT-12 v4 Expression BeadChip; Illumina). This high-density oligonucleotide array chip targets more than 47,000 probe sequences derived from National Center for Biotechnology Information Reference Sequence (NCBI) RefSeq Release 38 (November 7, 2009) and other sources. Data were background-corrected using Genome Studio (Illumina) and were quantile-normalized. Genes showing detection P <0.05 with fold change >1.5 were selected as suggested by the manufacturer (Illumina). Genes which are differentially associated with H2A.Z in LD611 cancer cells were functionally analyzed in the context of gene ontology and molecular networks by using Ingenuity pathway software (IPA; http://www.ingenuity.com). Differentially regulated genes were categorized into various functional groups (threshold P <0.05) and mapped to genetic networks.
RNA interference, qRT-PCR, and ChIP
For shRNA-based knockdown, DNA oligonucleotides encoding shRNAs specific for H2A.Z mRNA (5′-GCTTCAAAGAAGCTATTGATT-3′), WDR5 (5′-GAGAGTGGCTGGCAAGTTCAT-3′) and BPTF mRNA (5′-CGCCACTAACAGAGAAGGATT-3′) were annealed and ligated into the lentiviral expression vector pLKO.1 (Addgene, Cambridge, MA, USA). Lentivirus particles were generated in 293T cells by co-transfecting plasmids encoding VSV-G, NL-BH and the shRNAs. For H2A.Z, WDR5 and BPTF knockdown, LD611 cells were infected with these viruses and selected with puromycin (2 μg/ml) for two weeks. For qRT-PCR, total RNA (2 μg) was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA) and the PerfeCta™ SYBR Green FastMix (Quanta BioSciences Gaithersburg, MD, USA) as described . All samples were run in triplicate, and results were averaged. Sequences of the primers used for qRT-PCR are listed in Additional file 6: Table S5. For conventional ChIP assays, LD611 cells were harvested, fixed with 1% formaldehyde and processed for immunoprecipitation using antibodies against H2A.Z, WDR5, BPTF, and H3K4me1/me2/me3 as recently described . qPCR was performed in triplicate using the primers listed in Additional file 6: Table S5.
Nucleosome purification and protein identification
Nuclei were prepared from LD611 cells expressing Flag and HA-tagged H2A or H2A.Z and were digested with micrococcal nuclease to produce predominantly mononucleosomes. Mononucleosomes containing ectopic H2A or H2A.Z were subjected to anti-Flag M2 agarose. After extensive washing with wash buffer (20 mM HEPES-KOH, pH 7.9, 0.5 mM EDTA, 300 mM NaCl, 1 mM dithiothreitol, 10% glycerol, and 0.1% Nonidet P-40), the eluates were further purified using anti-HA agarose affinity chromatography. The imunoprecipitated nucleosome samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) as described .
Cell proliferation and migration assays
Cell proliferation was assessed by the 3–4, 5-(dimethyl-thyazol-2-yl)-2, 5-diphenyltetrazolium (MTT) assay as previously described . In brief, cells were seeded in 24-well tissue culture plates at a density of 2 × 104 and treated with the MTT labeling reagent (0.5 mg/ml) at 37°C for 1 h. The blue MTT formazan precipitate was dissolved with the MTT solvent (0.2 ml) and measured at a wavelength of 570 nm using a microplate reader (Bio-Rad). To measure the cell migration activity, Transwell migration assays were performed using 5 × 104 cells. Cells suspended in serum-free medium were plated on the Transwell filters (8-μm pore size; Corning, Corning, NY, USA), and DMEM supplemented with 10% FBS was used as chemoattractant. Cells were stained with 0.5% crystal violet and quantified after migration for 18 h.
We thank Peter Jones for the UROtsa and LD611 cell lines.
- Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997, 389: 251-260. 10.1038/38444.View ArticlePubMedGoogle Scholar
- Kusch T, Workman JL: Histone variants and complexes involved in their exchange. Subcell Biochem. 2007, 41: 91-109.PubMedGoogle Scholar
- Kouzarides T: Chromatin modifications and their function. Cell. 2007, 128: 693-705. 10.1016/j.cell.2007.02.005.View ArticlePubMedGoogle Scholar
- Talbert PB, Henikoff S: Histone variants-ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol. 2010, 11: 264-275.View ArticlePubMedGoogle Scholar
- Wang GG, Allis CD, Chi P: Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med. 2007, 13: 373-380. 10.1016/j.molmed.2007.07.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Zlatanova J, Thakar A: H2A.Z: view from the top. Structure. 2008, 16: 166-179. 10.1016/j.str.2007.12.008.View ArticlePubMedGoogle Scholar
- Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K: High-resolution profiling of histone methylations in the human genome. Cell. 2007, 129: 823-837. 10.1016/j.cell.2007.05.009.View ArticlePubMedGoogle Scholar
- Guillemette B, Bataille AR, Gevry N, Adam M, Blanchette M, Robert F, Gaudreau L: Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning. PLoS Biol. 2005, 3: e384-10.1371/journal.pbio.0030384.PubMed CentralView ArticlePubMedGoogle Scholar
- Mavrich TN, Jiang C, Ioshikhes IP, Li X, Venters BJ, Zanton SJ, Tomsho LP, Qi J, Glaser RL, Schuster SC, Gilmour DS, Albert I, Pugh BF: Nucleosome organization in the Drosophila genome. Nature. 2008, 453: 358-362. 10.1038/nature06929.PubMed CentralView ArticlePubMedGoogle Scholar
- Raisner RM, Hartley PD, Meneghini MD, Bao MZ, Liu CL, Schreiber SL, Rando OJ, Madhani HD: Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Cell. 2005, 123: 233-248. 10.1016/j.cell.2005.10.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Whittle CM, McClinic KN, Ercan S, Zhang X, Green RD, Kelly WG, Lieb JD: The genomic distribution and function of histone variant HTZ-1 during C. elegans embryogenesis. PLoS Genet. 2008, 4: e1000187-10.1371/journal.pgen.1000187.PubMed CentralView ArticlePubMedGoogle Scholar
- Gallant-Behm CL, Ramsey MR, Bensard CL, Nojek I, Tran J, Liu M, Ellisen LW, Espinosa JM: DeltaNp63alpha represses anti-proliferative genes via H2A.Z deposition. Genes Dev. 2012, 26: 2325-2336. 10.1101/gad.198069.112.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA: Gene reactivation by 5-aza-2′-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. PLoS Genet. 2012, 8: e1002604-10.1371/journal.pgen.1002604.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang H, Roberts DN, Cairns BR: Genome-wide dynamics of Htz1, a histone H2A variant that poises repressed/basal promoters for activation through histone loss. Cell. 2005, 123: 219-231. 10.1016/j.cell.2005.08.036.PubMed CentralView ArticlePubMedGoogle Scholar
- Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S: Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature. 2008, 456: 125-129. 10.1038/nature07324.PubMed CentralView ArticlePubMedGoogle Scholar
- Henikoff S, Henikoff JG, Sakai A, Loeb GB, Ahmad K: Genome-wide profiling of salt fractions maps physical properties of chromatin. Genome Res. 2009, 19: 460-469.PubMed CentralView ArticlePubMedGoogle Scholar
- Tolstorukov MY, Kharchenko PV, Goldman JA, Kingston RE, Park PJ: Comparative analysis of H2A.Z nucleosome organization in the human and yeast genomes. Genome Res. 2009, 19: 967-977. 10.1101/gr.084830.108.PubMed CentralView ArticlePubMedGoogle Scholar
- Suto RK, Clarkson MJ, Tremethick DJ, Luger K: Crystal structure of a nucleosome core particle containing the variant histone H2A.Z. Nat Struct Biol. 2000, 7: 1121-1124. 10.1038/81971.View ArticlePubMedGoogle Scholar
- Weber CM, Henikoff JG, Henikoff S: H2A.Z nucleosomes enriched over active genes are homotypic. Nat Struct Mol Biol. 2010, 17: 1500-1507. 10.1038/nsmb.1926.PubMed CentralView ArticlePubMedGoogle Scholar
- Conerly ML, Teves SS, Diolaiti D, Ulrich M, Eisenman RN, Henikoff S: Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Res. 2010, 20: 1383-1390. 10.1101/gr.106542.110.PubMed CentralView ArticlePubMedGoogle Scholar
- Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, Krausz TN, Olopade OI, Rimm DL, White KP: Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol. 2008, 4: 188.PubMed CentralView ArticlePubMedGoogle Scholar
- Svotelis A, Gevry N, Grondin G, Gaudreau L: H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle. 2010, 9: 364-370. 10.4161/cc.9.2.10465.View ArticlePubMedGoogle Scholar
- Valdes-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ, Stirzaker C, Clark SJ: Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res. 2012, 22: 307-321. 10.1101/gr.118919.110.PubMed CentralView ArticlePubMedGoogle Scholar
- Hebenstreit D, Gu M, Haider S, Turner DJ, Lio P, Teichmann SA: EpiChIP: gene-by-gene quantification of epigenetic modification levels. Nucleic Acids Res. 2011, 39: e27-10.1093/nar/gkq1226.PubMed CentralView ArticlePubMedGoogle Scholar
- Choi J, Heo K, An W: Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A. Nucleic Acids Res. 2009, 37: 5993-6007. 10.1093/nar/gkp660.PubMed CentralView ArticlePubMedGoogle Scholar
- Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ: Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature. 2006, 442: 91-95.View ArticlePubMedGoogle Scholar
- Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL, Roeder RG, Brivanlou AH, Allis CD: WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell. 2005, 121: 859-872. 10.1016/j.cell.2005.03.036.View ArticlePubMedGoogle Scholar
- Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD: A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 2006, 442: 86-90.PubMedGoogle Scholar
- Gevry N, Chan HM, Laflamme L, Livingston DM, Gaudreau L: p21 transcription is regulated by differential localization of histone H2A.Z. Genes Dev. 2007, 21: 1869-1881. 10.1101/gad.1545707.PubMed CentralView ArticlePubMedGoogle Scholar
- Draker R, Ng MK, Sarcinella E, Ignatchenko V, Kislinger T, Cheung P: A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation. PLoS Genet. 2012, 8: e1003047-10.1371/journal.pgen.1003047.PubMed CentralView ArticlePubMedGoogle Scholar
- Pandey R, Dou Y: H2A.Z sets the stage in ESCs. Cell Stem Cell. 2013, 12: 143-144. 10.1016/j.stem.2013.01.012.View ArticlePubMedGoogle Scholar
- Watanabe S, Radman-Livaja M, Rando OJ, Peterson CL: A histone acetylation switch regulates H2A.Z deposition by the SWR-C remodeling enzyme. Science. 2013, 340: 195-199. 10.1126/science.1229758.PubMed CentralView ArticlePubMedGoogle Scholar
- Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, Allis CD, Roeder RG: Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol. 2006, 13: 713-719. 10.1038/nsmb1128.View ArticlePubMedGoogle Scholar
- Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, Wysocka J, Allis CD, Chait BT, Hess JL, Roeder RG: Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell. 2005, 121: 873-885. 10.1016/j.cell.2005.04.031.View ArticlePubMedGoogle Scholar
- Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W: NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell. 1998, 2: 851-861. 10.1016/S1097-2765(00)80299-3.View ArticlePubMedGoogle Scholar
- Kim K, Heo K, Choi J, Jackson S, Kim H, Xiong Y, An W: Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. Mol Cell Biol. 2012, 32: 783-796. 10.1128/MCB.06037-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Li H, Ruan J, Durbin R: Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008, 18: 1851-1858. 10.1101/gr.078212.108.PubMed CentralView ArticlePubMedGoogle Scholar
- Hebenstreit D, Teichmann SA: Analysis and simulation of gene expression profiles in pure and mixed cell populations. Phys Biol. 2011, 8: 035013-10.1088/1478-3975/8/3/035013.View ArticlePubMedGoogle Scholar
- Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP: Integrative genomics viewer. Nat Biotechnol. 2011, 29: 24-26. 10.1038/nbt.1754.PubMed CentralView ArticlePubMedGoogle Scholar
- Heo K, Kim JS, Kim K, Kim H, Choi J, Yang K, An W: Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1. Oncogene. 2013, 32: 2510-2520. 10.1038/onc.2012.273.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.